Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): Current limitations and future directions

Alzheimer Disease and Associated Disorders

Volumn 21, Issue 4, 2007, Pages

  Rascovsky, Katya ^a   Hodges, John R ^e   Kipps, Christopher M ^f   Johnson, Julene K ^a   Seeley, William W ^a   Mendez, Mario F ^b   Knopman, David ^g   Kertesz, Andrew ^h   Mesulam, Marsel ^j   Salmon, David P ^c   Galasko, Douglas ^c,d   Chow, Tiffany W ⁱ   DeCarli, Charles ^k   Hillis, Argye ^l   Josephs, Keith ^g   Kramer, Joel H ^a   Weintraub, Sandra ^j   Grossman, Murray ^m   Gorno Tempini, Maria Luisa ^a   Miller, Bruce M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ ROTMAN RESEARCH INSTITUTE   (Canada)

^j NORTHWESTERN UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Behavioral variant; Diagnostic criteria; Differential diagnosis; Frontotemporal dementia; International consortium

Indexed keywords

AMNESIA; APHASIA; BEHAVIOR CHANGE; BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA; CLINICAL FEATURE; CONFERENCE PAPER; DEPRESSION; DETERIORATION; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISTRACTIBILITY; FRONTOTEMPORAL DEMENTIA; GENETICS; HUMAN; HYPOCHONDRIASIS; IMPULSIVENESS; MOOD DISORDER; PATHOLOGY; PRIORITY JOURNAL; STEREOTYPY;

DEMENTIA; HUMANS; NEUROLOGY;

EID: 37349044615     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31815c3445     Document Type: Conference Paper

References (85)

1. Mendez MF, Selwood A, Mastri AR, et al. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology. 1993;43:289-292.
2. Varma AR, Snowden JS, Lloyd JJ, et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1999;66:184-188.
3. Kumar-Singh S, Van Broeckhoven C. Frontotemporal lobar degeneration: current concepts in the light of recent advances. Brain Pathol. 2007;17:104-114.
4. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702-705.
5. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916-919.
6. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920-924.
7. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 1998;43:815-825.
8. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005;37:806-808.
9. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A. 1998;95:7737-7741.
10. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377-381.
11. Rascovsky K, Salmon DP, Lipton A, et al. Rate of progression differs in Frontotemporal Dementia and Alzheimer's Disease. Neurology. 2005;65:397-403.
12. Chow TW, Hynan LS, Lipton AM. MMSE scores decline at a greater rate in frontotemporal degeneration than in AD. Dement Geriatr Cogn Disord. 2006;22:194-199.
13. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65:719-725.
14. Lebert F, Stekke W, Hasenbroekx C, et al. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord. 2004;17:355-359.
15. Moretti R, Torre P, Antonello RM, et al. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol. 2003;49:13-19.
16. Pasquier F, Fukui T, Sarazin M, et al. Laboratory investigations and treatment in frontotemporal dementia. Ann Neurol. 2003;54(suppl 5):S32-S35.
17. Swartz JR, Miller BL, Lesser IM, et al. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry. 1997;58:212-216.
18. Huey ED, Putnam KT, Grafman J. A systematic review of neuro-transmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66:17-22.
19. Merrilees JJ, Miller BL. Long-term care of patients with frontotemporal dementia. J Am Med Directors Assoc. 2003;4:S162-S164.
20. Perry RJ, Miller BL. Behavior and treatment in frontotemporal dementia. Neurology. 2001;56:S46-S51.
21. Robinson KM. Rehabilitation applications in caring for patients with Pick's disease and frontotemporal dementias. Neurology. 2001;56:S56-S58.
22. Talerico KA, Evans LK. Responding to safety issues in frontotemporal dementias. Neurology. 2001;56:S52-S55.
23. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57:416-418.
24. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
25. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001;58:1803-1809.
26. Brun A. Frontal lobe degeneration of the non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr. 1987;6:193-208.
27. Brun A, Gustafson L. The Lund longitudinal dementia study. A 25 year perspective on neuropathology, differential diagnosis, and treatment. In: Corain B, Iqbal K, Nicolini M, et al, eds. Alzheimer's Disease: Advances in Clinical and Basic Research. London: John Wiley & Sons; 1993.
28. Neary D, Snowden JS, Northen B, et al. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry. 1988;51:353-361.
29. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11:592-598.
30. Hodges JR, Patterson K, Oxbury S, et al. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain. 1992;115(Pt 6):1783-1806.
31. Snowden JS. Semantic dysfunction in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 1999;10(suppl 1):33-36.
32. Hodges JR, Garrard P, Patterson K, eds. Semantic Dementia. New York: Wiley-Liss; 1998.
33. Hodges JR, Patterson K. Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study. J Int Neuropsychol Soc. 1996;2:511-524.
34. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:41-48.
35. Kertesz A, Munoz D. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord. 2004;17:282-286.
36. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077-1079.
37. Mendez MF, Perryman KM. Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review. J Neuropsychiatry Clin Neurosci. 2002;14:424-429.
38. Le Ber I, Guedj E, Gabelle A, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain. 2006;129:3051-3065.
39. de Vugt ME, Riedijk SR, Aalten P, et al. Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;22:35-41.
40. Hirono N, Mori E, Tanimukai S, et al. Distinctive neurobehavioral features among neurodegenerative dementias. J Neuropsychiatry Clin Neurosci. 1999;11:498-503.
41. Kertesz A, Nadkarni N, Davidson W, et al. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000;6:460-468.
42. Liu W, Miller BL, Kramer JH, et al. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology. 2004;62:742-748.
43. Mendez MF, Shapira JS, Miller BL. Stereotypical movements and frontotemporal dementia. Mov Disord. 2005;20:742-745.
44. Miller BL, Ikonte C, Ponton M, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology. 1997;48:937-942.
45. Nyatsanza S, Shetty T, Gregory C, et al. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2003;74:1398-1402.
46. Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 2005;236:43-48.
47. Ikeda M, Brown J, Holland AJ, et al. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;73:371-376.
48. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 2002;58:1608-1615.
49. Rascovsky K, Neuhaus J, Kramer J, et al. Utility of supportive features in the clinical diagnosis of frontotemporal lobal degeneration. Neurology. 2006;66:A192-A193.
50. Bozeat S, Gregory CA, Ralph MA, et al. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 2000;69:178-186.
51. Levy ML, Miller BL, Cummings JL, et al. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol. 1996;53:687-690.
52. Chan D, Walters RJ, Sampson EL, et al. EEG abnormalities in frontotemporal lobar degeneration. Neurology. 2004;62:1628-1630.
53. Passant U, Warkentin S, Gustafson L. Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics. Int J Geriatr Psychiatry. 1997;12:395-403.
54. Rascovsky K, Ross L, Salmon D, et al. Inter-rater reliability of diagnostic criteria for Frontotemporal Dementia (FTD): findings from the California non-AD diagnostic reliability consortium. Neurology. 2007;68(suppl 1):A354.
55. Howorth P, Saper J. The dimensions of insight in people with dementia. Aging Ment Health. 2003;7:113-122.
56. Mendez MF, Shapira JS. Loss of insight and functional neuroimaging in frontotemporal dementia. J Neuropsychiatry Clin Neurosci. 2005;17:413-416.
57. Evers K, Kilander L, Lindau M. Insight in frontotemporal dementia: conceptual analysis and empirical evaluation of the consensus criterion "loss of insight" in frontotemporal dementia. Brain Cogn. 2007;63:13-23.
58. Knopman DS, Boeve BF, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol. 2005;57:480-488.
59. Graham A, Davies R, Xuereb J, et al. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005;128:597-605.
60. Diehl J, Grimmer T, Drzezga A, et al. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging. 2004;25:1051-1056.
61. Du AT, Schuff N, Kramer JH, et al. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain. 2007;130:1159-1166.
62. Bocti C, Rockel C, Roy P, et al. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;21:364-372.
63. Charpentier P, Lavenu I, Defebvre L, et al. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry. 2000;69:661-663.
64. Grossman M, McMillan C, Moore P, et al. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain. 2004;127:628-649.
65. Franceschi M, Anchisi D, Pelati O, et al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol. 2005;57:216-225.
66. Frisoni GB, Beltramello A, Geroldi C, et al. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1996;61:157-165.
67. Grimmer T, Diehl J, Drzezga A, et al. Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study. Dement Geriatr Cogn Disord. 2004;18:32-36.
68. Jeong Y, Cho SS, Park JM, et al. 18F-FDG PET Findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med. 2005;46:233-239.
69. Kipps CM, Davies RR, Mitchell J, et al. Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord. 2007;23:334-342.
70. McNeill R, Sare GM, Manoharan M, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2007;78:350-355.
71. Nakano S, Asada T, Yamashita F, et al. Relationship between antisocial behavior and regional cerebral blood flow in frontotemporal dementia. Neuroimage. 2006;32:301-306.
72. Perry RJ, Graham A, Williams G, et al. Patterns of frontal lobe atrophy in frontotemporal dementia: a volumetric MRI study. Dement Geriatr Cogn Disord. 2006;22:278-287.
73. Peters F, Perani D, Herholz K, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;21:373-379.
74. Read SL, Miller BL, Mena I, et al. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc. 1995;43:1243-1247.
75. Rosen HJ, Gorno-Tempini ML, Goldman WP, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 2002;58:198-208.
76. Salibi NA, Lourie GL, Lourie H. A variant of normal-pressure hydrocephalus simulating Pick's disease on computerized tomography. Report of two cases. J Neurosurg. 1983;59:902-904.
77. Seeley W, Crawford R, Rascovsky K, et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol. 2008. In press.
78. Schroeter ML, Raczka K, Neumann J, et al. Towards a nosology for frontotemporal lobar degenerations-A meta-analysis involving 267 subjects. Neuroimage. 2007.
79. Sjogren M, Gustafson L, Wikkelso C, et al. Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dement Geriatr Cogn Disord. 2000;11:275-285.
80. Short RA, Broderick DF, Patton A, et al. Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes. Arch Neurol. 2005;62:1106-1110.
81. Starkstein SE, Migliorelli R, Teson A, et al. Specificity of changes in cerebral blood in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry. 1994;57:790-796.
82. Varma AR, Adams W, Lloyd JJ, et al. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand. 2002;105:261-269.
83. Whitwell JL, Josephs KA, Rossor MN, et al. Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol. 2005;62:1402-1408.
84. Foster NL, Heidebrink JL, Clark CM, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007;130:2616-2635.
85. Jagust W, Reed B, Mungas D, et al. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology. 2007;69:871-877.